1-(2-((4-Chlorophenyl)(phenyl)methoxy)ethyl)piperidine hydrochloride, 95.0%, 1g

5,6-Dichloronicotinic acid, 98.0%, 5g

3,5-dimethyl-2-pyridinamine hydrochloride, 95.0%, 1g

3-{[2-(pyrrolidin-1-yl)phenyl]imino}-2,3-dihydro-1??,2-benzothiazole-1,1-dione, 98+%, 100mg

3-Fluoro-4-methoxybenzaldehyde, 98.0%, 100g

N-(2-Bromothiazol-4-yl)-2,2,2-trifluoroacetamide, 95.0%, 250mg

Ácido etilendiaminotetraacético, mínimo 99 %, pa, ACS, 2,5 kg, envase de plástico.

2-Bromo-4-hexylthiophene>98.0%(GC)1g

Methyl 2-bromo-5-chlorobenzoate, 98.0%, 500g

GSK-J4, 97%, 25mg

((5-Thiazolyl)methyl)-(4-nitrophenyl)carbonate, 95.0%, 25g

1,1,1,5,5,6,6,7,7,7-Decafluoro-2,4-heptanedione, 97.0%, 1g

(3-(Ethylsulfonamido)phenyl)boronic acid, 98%, 250mg